| Not Yet Recruiting | Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikung Dengue, Chikungunya | Phase 3 | 2026-03-31 |
| Recruiting | Butantan-DV Vaccine in Elderly Populations (DEN-04-IB) Dengue | Phase 3 | 2026-03-03 |
| Recruiting | Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted Avian Influenza A Virus | Phase 1 / Phase 2 | 2025-09-10 |
| Completed | Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants an Influenza, Human | Phase 3 | 2023-04-25 |
| Completed | Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine Coronavirus Infections, Healthy | Phase 2 / Phase 3 | 2023-02-28 |
| Completed | Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Den Dengue | Phase 2 | 2023-02-15 |
| Completed | A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolesce Chikungunya | Phase 3 | 2022-01-31 |
| Completed | Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil Coronavirus Infections, Healthy | Phase 1 | 2021-07-09 |
| Completed | Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine Influenza, Human | Phase 3 | 2021-05-12 |
| Completed | Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine SARS-CoV-2 Acute Respiratory Disease | — | 2021-05-10 |
| Withdrawn | Clinical Trial to Assess Safety and Immunogenicity of a Synthetic Vaccine Against Streptococcus Pyogenes Rheumatic Fever | Phase 1 | 2021-05-01 |
| Unknown | Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases Immunosuppression, Cancer, COVID-19 | Phase 1 / Phase 2 | 2021-05-01 |
| Completed | An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine Covid19 | Phase 4 | 2021-02-07 |
| Completed | Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA) COVID-19 | — | 2020-10-25 |
| Completed | Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Profe COVID-19 | Phase 3 | 2020-07-21 |
| Completed | Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo COVID, SARS-CoV 2 | — | 2020-06-01 |
| Completed | Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vac Influenza | Phase 4 | 2019-04-22 |
| Completed | Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil Influenza, H7N9 Influenza | Phase 1 | 2018-09-24 |
| Completed | Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2 Influenza, Human, Orthomyxoviridae Infections, RNA Virus Infections | — | 2018-04-23 |
| Completed | Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Influenza Vaccines | — | 2017-04-06 |
| Unknown | Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine Dengue | Phase 3 | 2016-02-22 |
| Completed | Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Eld Influenza | — | 2015-04-01 |
| Completed | Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients Human Influenza | Phase 4 | 2014-04-01 |
| Completed | Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB Influenza | — | 2014-04-01 |
| Unknown | Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine Dengue | Phase 2 | 2013-10-01 |
| Completed | Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine Influenza | — | 2013-06-01 |
| Completed | Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pr Immunocompromised Patients, Safety of Pandemic Influenza A (H1N1)Vaccine, Immunogenicity of Pandemic Influenza A (H1N1)Vaccine | — | 2010-04-01 |
| Completed | Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines Influenza | Phase 1 | 2010-01-01 |
| Completed | Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza Influenza, Acute Respiratory Infection | Phase 4 | 2009-05-01 |
| Completed | Rotavirus Vaccine Produced by Butantan Institute Rotavirus Infections | Phase 1 | 2009-03-01 |